Risk Factors and Outcomes of Multidrug-resistant Pseudomonas aeruginosa in Kelantan, Malaysia: A Multicenter Case–control Study
Background: Increasing trend and spread of multidrug-resistant Pseudomonas aeruginosa (MDR-PA) in clinical settings is a great challenge in managing patients with infections caused by this pathogen. Objective: To determine the risk factors and outcomes of MDR-PA acquisition in the northeastern state...
Saved in:
| Main Authors: | Siti Norfairuz Md. Salim, Nurul Izzah Md Din, Rosnita Rashid, Sharifah Aisyah Sayed Hitam, Zakuan Zainy Deris |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | Saudi Journal of Medicine and Medical Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/sjmms.sjmms_429_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multidrug-resistant Pseudomonas aeruginosa in immunocompromised cancer patients: epidemiology, antimicrobial resistance, and virulence factors
by: Asmaa Abdulhak, et al.
Published: (2025-06-01) -
Mechanisms of ceftolozane/tazobactam resistance in Pseudomonas aeruginosa isolates from South Korea
by: Yu Mi Wi, et al.
Published: (2024-12-01) -
Ceftazidime-Induced Overexpression of MexJK-OprM Confers Resistance to Ceftolozane/Tazobactam in an Isolate of Pseudomonas aeruginosa
by: Sato T, et al.
Published: (2025-08-01) -
Ceftolozane/tazobactam use and emergence of resistance: a 4-year analysis of antimicrobial susceptibility in Pseudomonas aeruginosa isolates in a tertiary hospital
by: Alessandra Imeneo, et al.
Published: (2025-04-01) -
In vitro activity of ceftolozane/tazobactam against ESBL-producing enterobacterales in China: SMART 2016–2019
by: Wei Yu, et al.
Published: (2025-05-01)